Genoa Healthcare debuts 14 pharmacies
Genoa Healthcare, a provider of pharmacy, outpatient telepsychiatry and medication management services, has expanded with the opening of 14 pharmacies.
Genoa has opened in the following locations Laredo, Texas; Grants Pass, Ore.; Hannibal, Ore.; Lufkin, Texas; Weslaco, Texas; Toledo, Ohio; Valley Cottage, N.Y.; Biddeford, Maine; St. Louis Park, Minn.; Hartford, Conn; Eugene, Ore.; New Port Richey, Fla.; Tallahassee, Fla,; and Williamsburg, Va.
These new locations bring the total number of pharmacies opened this year to 51 for a total of 437 pharmacies.
“Genoa Healthcare is grateful to be working with our center partners in these communities to bring quality service to those struggling with behavioral and other complex health conditions,” the company said.
Hikma, Vectura to develop generic versions of GSK’s Ellipta portfolio
Hikma Pharmaceuticals has signed an agreement with Vectura Group for the global development and commercialization of generic versions of GlaxoSmithKlines’s Ellipta portfolio, which will utilize Vectura’s proprietary “open-inhale-close” dry powder inhaler device.
“The generic respiratory market is a key area of pipeline focus for Hikma.This agreement leverages the investment we have made and the experience we have gained through our generic Advair Diskus program,” Hikma CEO Siggi Olafsson said in a statement. “By strengthening and expanding our partnership with Vectura, we will develop a pipeline of complex respiratory products that will enable us to deliver sustainable long-term growth.”
Vectura and Hikma believe the open-inhale-close dry powder inhaler device has the potential to be developed as a drug-device combination for generic versions of the GSK Ellipta portfolio.
Net sales for Ellipta products in the United States are projected to be $4 billion by 2024 and approximately $5.5 billion globally, the company said.
The open-inhale-close dry powder inhaler program includes the development of generics of up to five GSK respiratory medicines.
Hikma and Vectura have agreed to develop and commercialize at least three of the portfolio products. A generic version of Breo Ellipta (fluticasone furoate and vilanterol trifenatate) will be prioritized for the first wave of development. Pharmaceutical and device development work has progressed in parallel with partnering discussions.
The new device, an evolution of Vectura’s lever-operated multidose device, builds on Vectura and Hikma’s shared experience with the generic Advair Diskus program, enabling accelerated development under this new agreement.
PhRMA to roll out ‘Roadmap to Health’ in NYC
The Pharmaceutical Research and Manufacturers of America, New York Health Works and assembly member Marcos Crespo announced a new mobile health screening program, the “Roadmap to Health,” which will launch in January 2019 in New York City.
Dozens of events will take place throughout the upcoming year, providing various healthcare screenings and educational resources about health and wellness.
The Roadmap to Health is a mobile health fair that will provide information and resources to New York residents to help combat chronic disease and empower individuals with knowledge about their health, initially focusing on neighborhoods in the Bronx, Brooklyn and Queens.
Biometric health screenings will be available at each event, offering such screenings as total cholesterol, HDL cholesterol, blood pressure and BMI. Blood glucose screening, vision screening and a pulmonary function test also will be available at a number of events.
An independent medical screening firm will administer and conduct all of the health screenings. At each location, screeners will be on site to provide services in Spanish and English. Individuals who are screened also will be provided information on where to seek further medical assistance within their communities, if they choose to do so. All screenings will be provided to communities free of charge. PhRMA will be working alongside legislators to make sure their constituents are aware of this important resource.
The Roadmap to Health mobile health fair aims to remove barriers to health care by partnering with community organizations, health clinics and faith-based centers and providing direct services to individuals in their own communities. Each event can be tailored to meet the needs of each organization or community. At various points throughout the program, a nutritionist will be available to advise participants about the importance of healthy eating, or a group exercise class may be offered by a community partner.
“Many communities, particularly communities of color, face barriers in accessing preventative care,” said assembly member Crespo. “The Roadmap to Health program helps break down those barriers by bringing vital services to our communities, and I’d like to thank PhRMA for launching this important program.”
“We are thrilled to sponsor the Roadmap to Health program. Regular screenings are key to detecting and treating early warning signs of chronic disease,” PhRMA vice president of medical affairs and strategic alliances Michael Ybarra said. “PhRMA supports expanding access to care, and we hope to empower the vibrant communities of New York City with information and resources to improve their health.”